Steroid sulfatase (STS) is an attractive target for a range of oestrogen-and androgen- dependent diseases. In search of novel chemotypes of STS inhibitors, we had previously identified nortropinyl–arylsulfonylureas 1; however, while these compounds were good inhibitors of purified STS (lowest Ki= 76nM), they showed only weak inhibition of STS activity in cells (lowest IC50 around 2μM). Extended structure–activity relationship studies ...